Session Details

S023 Nail Symposium

Sat, Mar 20, 9:00 AM - 12:00 PM
3 CME Available Symposium

DESCRIPTION

This session provides the most comprehensive up-to-date information on diagnosis and treatment of major nail disorders. Recognized experts from around the world will discuss the most current scientific evidence regarding onychomycosis, nail unit psoriasis, nail unit lichen planus, nail unit squamous cell carcinoma, nail unit melanoma, nail disorders in skin of color patients, onychoscopy, advanced nail imaging, as well as other key nail topics.

LEARNING OBJECTIVES

1.

Describe the most up to date therapy for patients with nail psoriasis.

2.

Manage patients with onychomycosis and terbinafine resistance.

3.

Describe the most up to date information on the treatment of nail unit melanoma.

SCHEDULE

9:00 AM

Advances in the Diagnosis of Nail Unit Tumors

Dong-Youn Lee, MD, PhD, IFAAD

9:10 AM

Update on Nail Disorders in Skin of Color

Brian William Morrison, MD, MSc, FAAD

9:20 AM

Surgical and Non-Surgical Management of Ingrown Nails

Jorge Ocampo-Garza, MD, IFAAD

9:30 AM

Expert Post-Surgical Nail Care: Ensuring Optimal Healing

Judith Dominguez-Cherit, MD

9:40 AM

Preventing and Managing Nail Surgical Complications

Bertrand Richert, MD, PhD, IFAAD

9:50 AM

Questions and Answers

Judith Dominguez-Cherit, MD, Dong-Youn Lee, MD, PhD, IFAAD, Brian William Morrison, MD, MSc, FAAD, Jorge Ocampo-Garza, MD, IFAAD, Bertrand Richert, MD, PhD, IFAAD

10:00 AM

Approach to Melanonychia

Adam Rubin, MD, FAAD

10:10 AM

Management of Pediatric Melanonychia

Je-Ho Mun, MD, PhD

10:20 AM

State of the Art Management of Nail Unit Melanoma

Nathaniel J. Jellinek, MD, FAAD

10:30 AM

Modern Evaluation and Treatment of Nail Unit Squamous Cell Carcinoma

Julia O'Brien Baltz, MD, FAAD

10:40 AM

State of the Art Understanding of Nail Toxicities from Cytotoxic and Targeted Therapies

Angela Juan Jiang, MD, FAAD

10:50 AM

Questions and Answers

Adam Rubin, MD, FAAD, Julia O'Brien Baltz, MD, FAAD, Nathaniel J. Jellinek, MD, FAAD, Angela Juan Jiang, MD, FAAD, Je-Ho Mun, MD, PhD

11:00 AM

High-Yield Onychoscopy: Key Findings to Master

Bianca Maria Piraccini, MD, IFAAD

11:10 AM

Advanced Nail Unit Imaging

Matilde Iorizzo, PhD, MD, IFAAD

11:20 AM

State of the Art Management of Nail Unit Psoriasis

Shari Lipner, MD, PhD, FAAD

11:30 AM

State of the Art Treatment of Nail Unit Lichen Planus

Molly A. Hinshaw, MD, FAAD

11:40 AM

Diagnosis and Treatment of Onychomycosis in a World with Resistant Fungi

Avner Shemer, MD, IFAAD

11:50 AM

Questions and Answers

Molly A. Hinshaw, MD, FAAD, Matilde Iorizzo, PhD, MD, IFAAD, Shari Lipner, MD, PhD, FAAD, Bianca Maria Piraccini, MD, IFAAD, Avner Shemer, MD, IFAAD

DIRECTOR

Adam Rubin, MD, FAAD

Adam Rubin, MD, FAAD

NYU Grossman School of Medicine

SPEAKERS

Julia O'Brien Baltz, MD, FAAD

Julia O'Brien Baltz, MD, FAAD

Judith Dominguez-Cherit, MD

Judith Dominguez-Cherit, MD

Molly A. Hinshaw, MD, FAAD

Molly A. Hinshaw, MD, FAAD

University of Wisconsin School of Medicine and Public Health

Matilde Iorizzo, PhD, MD, IFAAD

Matilde Iorizzo, PhD, MD, IFAAD

Private Dermatology Practice, Lugano/Bellinzona (Switzerland)

Nathaniel J. Jellinek, MD, FAAD

Nathaniel J. Jellinek, MD, FAAD

Adult and Pediatric Dermatology

Angela Juan Jiang, MD, FAAD

Angela Juan Jiang, MD, FAAD

Oregon Health & Science University

Dong-Youn Lee, MD, PhD, IFAAD

Dong-Youn Lee, MD, PhD, IFAAD

Samsung Medical Center Sungkyunkwan University

Brian William Morrison, MD, MSc, FAAD

Brian William Morrison, MD, MSc, FAAD

Je-Ho Mun, MD, PhD

Je-Ho Mun, MD, PhD

Jorge Ocampo-Garza, MD, IFAAD

Jorge Ocampo-Garza, MD, IFAAD

Bianca Maria Piraccini, MD, IFAAD

Bianca Maria Piraccini, MD, IFAAD

Piraccini Medical Center, Bologna Italy

Bertrand Richert, MD, PhD, IFAAD

Bertrand Richert, MD, PhD, IFAAD

Avner Shemer, MD, IFAAD

Avner Shemer, MD, IFAAD

DISCLOSURES

Julia O'Brien Baltz, MD, FAAD

No financial relationships exist with ineligible companies.

Judith Dominguez-Cherit, MD

No financial relationships exist with ineligible companies.

Molly A. Hinshaw, MD, FAAD

BiaCure Therapies Inc – Founder(Stock); Elucent Medical – Stockholder Private Company(No Compensation Received); RevOps – Stockholder Private Company(No Compensation Received);

Matilde Iorizzo, PhD, MD, IFAAD

AbbVie – Investigator(Fees); Almirall – Speaker(Fees); Johnson and Johnson – Advisory Board(Fees); Laboratoires Bailleul – Advisory Board(Fees); Leo Pharma – Advisory Board(Fees); Springer Publishing – Other(Other Financial Benefit); Takeda Pharmaceuticals USA Inc – Advisory Board(Fees);

Nathaniel J. Jellinek, MD, FAAD

No financial relationships exist with ineligible companies.

Angela Juan Jiang, MD, FAAD

No financial relationships exist with ineligible companies.

Dong-Youn Lee, MD, PhD, IFAAD

No financial relationships exist with ineligible companies.

Brian William Morrison, MD, MSc, FAAD

No financial relationships exist with ineligible companies.

Je-Ho Mun, MD, PhD

No financial relationships exist with ineligible companies.

Jorge Ocampo-Garza, MD, IFAAD

No financial relationships exist with ineligible companies.

Bianca Maria Piraccini, MD, IFAAD

Difa Cooper – Consultant (1099 relationship)(Honoraria); Eli Lilly – Advisory Board(Fees); Giuliani Pharma – Consultant (1099 relationship)(Honoraria); L'Oréal France – Advisory Board(Fees); Pfizer Inc. – Consultant (1099 relationship)(Honoraria); Pierre Fabre Dermo Cosmetique France – Advisory Board(Fees);

Bertrand Richert, MD, PhD, IFAAD

No financial relationships exist with ineligible companies.

Adam Rubin, MD, FAAD

New York University Langone Medical Center – Employee – Lab does not sell products(Salary);

Avner Shemer, MD, IFAAD

No financial relationships exist with ineligible companies.